Aurobindo gets US nod for anti-HIV infection tablets
|
Last Updated: Thu, Mar 12, 2009 13:44 hrs
Mumbai: Aurobindo Pharma on Thursday said it has received US health administrator's approval for Lopinavir/Ritonavir tablets used in the treatment of HIV infections.
|
Also
see
|
|||||
|
In a filing to the Bombay Stock Exchange, the pharma company said it has received approval from US Food and Drug Administration (US FDA) for tablets that are in the strength of 100/25 mg and 200/50 mg.
More India business stories | Get the latest Sensex update
Lopinavir/Ritonavir tablets are used in the treatment of HIV infection in adult and children above the age of two years, the filing added. Aurobindo now has a total of 93 Abbreviated New Drug Application approvals from US FDA.
most popular on facebook
talking point on sify finance
today's most read on sify finance
- Petrol price hike leaves people, parties fuming Read 1875 Times
- Petrol prices go up by over Rs 7.50 per litre Read 1230 Times
- Petrol price hike: India Inc welcomes move Read 723 Times
- Nude maid service raising eyebrows in Texas city Read 344 Times
- Gold holds strong, silver extends losses Read 202 Times
